Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for changeflow.com

ACME UNITED CORPORATION Class II Drug Recall

The FDA has initiated a Class II drug recall for ACME UNITED CORPORATION's Max Packaging Antibacterial Towelette due to CGMP deviations. The recall affects product distributed nationwide within the United States and is ongoing.

Urgent Enforcement Pharmaceuticals
Favicon for changeflow.com

ACME UNITED CORPORATION Class II Recall of Antiseptic Wipes

The FDA has announced a Class II recall for ACME UNITED CORPORATION's Medi-First Antiseptic Wipes due to CGMP deviations. The recall affects product distributed nationwide in the United States.

Urgent Enforcement Healthcare
Favicon for changeflow.com

ACME UNITED CORPORATION Class II Drug Recall

The FDA has initiated a Class II drug recall for Dukal BZK Antiseptic Towelettes manufactured by ACME UNITED CORPORATION due to CGMP deviations. The recall affects product distributed nationwide in the United States.

Urgent Enforcement Pharmaceuticals
Favicon for changeflow.com

FDA Class II Drug Recall: Harbin Jixianglong Semaglutide

The FDA has initiated a Class II recall for Semaglutide distributed by Harbin Jixianglong Biotech Co., Ltd. nationwide due to CGMP deviations, specifically failing to complete process validation and bacterial endotoxin method validation before distribution. The recall is ongoing.

Urgent Enforcement Pharmaceuticals
Favicon for changeflow.com

Mylan Pharmaceuticals Class II Drug Recall: Isotretinoin Capsules

The FDA has announced a Class II drug recall for Mylan Pharmaceuticals' Isotretinoin Capsules, USP 40 mg, due to failed dissolution specifications. The recall affects product distributed nationwide within the United States.

Urgent Enforcement Pharmaceuticals
Favicon for changeflow.com

Radnostix Class II Drug Recall for Sodium Iodide

The FDA has initiated a Class II drug recall for Radnostix's Sodium Iodide (I-131) Solution, identified as D-0389-2026. The recall is due to the presence of particulate matter resulting from production issues and affects distribution nationwide in the USA and Puerto Rico.

Urgent Enforcement Pharmaceuticals
Favicon for changeflow.com

Teva Pharmaceuticals Class II Recall of Metoprolol Succinate Tablets

The FDA has issued a Class II recall for Teva Pharmaceuticals' Metoprolol Succinate Extended-Release Tablets due to failed dissolution specifications. The recall affects nationwide distribution and is currently ongoing.

Urgent Enforcement Pharmaceuticals
Favicon for changeflow.com

FDA Class II Recall of Antiseptic Wipes

The FDA has initiated a Class II recall for Green Guard Antiseptic Wipes due to CGMP deviations. The product was distributed nationwide in the United States. This recall is ongoing.

Urgent Enforcement Healthcare
Favicon for changeflow.com

Teva Pharmaceuticals USA, Inc. - Metoprolol Succinate Recall

The FDA has initiated a Class II recall for Teva Pharmaceuticals USA, Inc.'s Metoprolol Succinate Extended-Release Tablets (200 mg) due to failed dissolution specifications. The recall is nationwide and affects approximately 100-count bottles.

Urgent Enforcement Pharmaceuticals
Favicon for changeflow.com

ACME UNITED CORPORATION Class II Recall D-0370-2026 for Towelettes

The FDA has issued a Class II recall (D-0370-2026) for ACME UNITED CORPORATION's Cleansing Towelettes due to CGMP deviations. The recall is ongoing and affects nationwide distribution within the United States.

Urgent Enforcement Pharmaceuticals

Showing 4531–4540 of 35,317 changes

1 452 453 454 455 456 3532

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.